Related Experiment Video
Updated: May 28, 2026

Breathing-controlled Electrical Stimulation (BreEStim) for Management of Neuropathic Pain and Spasticity
Published on: January 10, 2013
Breathing-Controlled Electrical Stimulation (BreEStim) Selectively Modulates Affective and Cognitive Components of
Ahmad Z Rao1,2, Michael Houston3, Hao Meng1,2
1Department of Physical Medicine and Rehabilitation, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Breathing-controlled electrical stimulation (BreEStim) offers a non-pharmacological pain relief method. This study shows BreEStim modulates pain
Area of Science:
- Neuromodulation
- Pain Perception
- Neuroscience
Background:
- Breathing-controlled electrical stimulation (BreEStim) synchronizes breathing with electrical stimulation.
- Prior research indicates BreEStim has analgesic effects in healthy adults and SCI patients.
- The neural mechanisms underlying BreEStim's effects on pain components require further investigation.
Purpose of the Study:
- To investigate the neural effects of BreEStim on sensory, affective, and cognitive pain dimensions using EEG.
- To compare the neural impact of BreEStim with conventional electrical stimulation (EStim).
- To assess BreEStim's potential as a targeted, non-pharmacological pain management strategy.
Main Methods:
- A randomized, crossover within-subject design involving 14 healthy participants.
- EEG recordings and electrical pain thresholds (EPT) measured pre- and post-intervention.
- Analysis of event-related potentials (ERPs) for sensory/affective processing and resting-state EEG for cognitive processing.
Main Results:
- Both BreEStim and EStim increased EPT, indicating habituation.
- No significant changes in early sensory ERPs (P30) were observed.
- BreEStim selectively reduced the affective pain component (P250) and altered resting-state EEG spectral power (increased delta/theta, decreased alpha).
Conclusions:
- BreEStim preserves sensory pain encoding while selectively modulating affective and cognitive pain dimensions.
- BreEStim demonstrates potential as a targeted, non-pharmacological neuromodulation strategy for pain management.
- The findings support BreEStim's efficacy in altering neural activity associated with pain processing.
More Related Videos
08:33A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers
Published on: January 5, 2024
07:28Psychophysically-anchored, Robust Thresholding in Studying Pain-related Lateralization of Oscillatory Prestimulus Activity
Published on: January 21, 2017